Global demand for Hormone Replacement Therapy is anticipated to climb 7.1% year on year to US$ 12 billion in 2032.

The Hormone Replacement Therapy market grew strongly between 2020 and 2022, owing to increased prevalence of target disorders and the availability of long-acting hGH drugs. According to the American Thyroid Association, around 12.0% of the US population will suffer from thyroid disease during their lifetime. It further stated that around 20.0 million Americans suffer from thyroid illness.

A list of Key Players Covered in the Hormone Replacement Therapy Market Are:

  • Eli Lilly and Company
  • Pfizer, Inc.
  • AbbVie, Inc.
  • Novo Nordisk A/S
  • Merck KGaA
  • Mylan N.V.
  • Bayer Healthcare,
  • F. Hoffmann-La Roche Ltd.
  • Teva Pharmaceuticals,
  • Endo International,
  • Sun Pharmaceutical Industries Ltd,
  • Tolmar Pharmaceuticals, Inc.,
  • Novartis AG,
  • Upsher-Smith Laboratories Inc.,
  • SottoPelle,
  • Neuva Aesthetics,
  • Ascend Therapeutics

During menopause, several women experience painful symptoms such as vaginal dryness and hot flashes. Hormone therapy or menopausal hormone therapy, is considered as an efficient treatment option for menopausal symptoms as it balances the hormone levels in the body. On account of these factors, the demand for HRT is projected to surge during the forecast period.

In addition, demand for hormone replacement therapy increases with growing awareness related to biological drugs for treatment of cancer. The market for biologics and protein products has developed owing to innovations in analytics observed over the past two decades.

This is due to the advanced analytical techniques which allows an in-depth physicochemical comparison of complex protein molecules and protein drugs. This in turn helps in the research and development of new drugs and therapy.
As per FMI, the market presents high growth opportunities in emerging countries such as China and India. Emerging countries are focused upon improving their healthcare infrastructure due to increasing resources and large patient pool in these regions.

In addition, necessary medications are imported from developed regions due to the lack of several manufacturers in developing regions, which increases their cost. Hence, key players are expanding their manufacturing capacity to generate revenue from hormone replacement therapy.

Browse More@ https://www.futuremarketinsights.com/reports/hormone-replacement-therapy-market

Hormone Replacement Therapy Market: Segmentation

Based on Therapy Type:

  • Estrogen Replacement Therapy
  • Growth Hormone Replacement
  • Dopamine Agonist
  • Somatostatin Analogues
  • Thyroid Hormone Replacement
  • Tablets
  • Capsules
  • Injections

Based on Application:

  • Cancer
  • Menopause
  • Hypopituitarism
  • Hypothyroidism
  • Others

Based on Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies and Drugstores
  • Compounding Pharmacies
  • E-commerce
  • Others